PL364570A1 - Kompozycja i sposób iniekcji o kontrolowanym uwalnianiu - Google Patents

Kompozycja i sposób iniekcji o kontrolowanym uwalnianiu

Info

Publication number
PL364570A1
PL364570A1 PL02364570A PL36457002A PL364570A1 PL 364570 A1 PL364570 A1 PL 364570A1 PL 02364570 A PL02364570 A PL 02364570A PL 36457002 A PL36457002 A PL 36457002A PL 364570 A1 PL364570 A1 PL 364570A1
Authority
PL
Poland
Prior art keywords
composition
controlled release
release injections
injections
controlled
Prior art date
Application number
PL02364570A
Other languages
English (en)
Inventor
Bruce Roser
Castro Arcadio Garcia De
Original Assignee
Cambridge Biostability Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Biostability Ltd filed Critical Cambridge Biostability Ltd
Publication of PL364570A1 publication Critical patent/PL364570A1/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T428/00—Stock material or miscellaneous articles
    • Y10T428/29—Coated or structually defined flake, particle, cell, strand, strand portion, rod, filament, macroscopic fiber or mass thereof
    • Y10T428/2982—Particulate matter [e.g., sphere, flake, etc.]
    • Y10T428/2984—Microcapsule with fluid core [includes liposome]
    • Y10T428/2985—Solid-walled microcapsule from synthetic polymer

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
PL02364570A 2001-02-16 2002-02-14 Kompozycja i sposób iniekcji o kontrolowanym uwalnianiu PL364570A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/784,153 US6623762B2 (en) 2001-02-16 2001-02-16 Composition and method for controlled release injections
PCT/US2002/004269 WO2002066005A1 (en) 2001-02-16 2002-02-14 Composition and method for controlled release injections

Publications (1)

Publication Number Publication Date
PL364570A1 true PL364570A1 (pl) 2004-12-13

Family

ID=25131506

Family Applications (1)

Application Number Title Priority Date Filing Date
PL02364570A PL364570A1 (pl) 2001-02-16 2002-02-14 Kompozycja i sposób iniekcji o kontrolowanym uwalnianiu

Country Status (13)

Country Link
US (1) US6623762B2 (pl)
EP (1) EP1359899A1 (pl)
JP (1) JP2004522764A (pl)
KR (1) KR100852389B1 (pl)
CN (1) CN1668275A (pl)
AU (1) AU2002251931B2 (pl)
CA (1) CA2438108C (pl)
MX (1) MXPA03007312A (pl)
NZ (1) NZ527714A (pl)
PL (1) PL364570A1 (pl)
RU (1) RU2313366C2 (pl)
WO (1) WO2002066005A1 (pl)
ZA (1) ZA200306375B (pl)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6623762B2 (en) 2001-02-16 2003-09-23 Cambridge Biostability Ltd. Composition and method for controlled release injections
GB0327727D0 (en) * 2003-11-28 2003-12-31 Quadrant Drug Delivery Ltd Viral microparticles
GB0517688D0 (en) * 2005-08-31 2005-10-05 Cambridge Biostability Ltd Improvements in the stabilisation of biological materials
GB2430880A (en) * 2005-10-04 2007-04-11 Cambridge Biostability Ltd Pharmaceutical compositions stabilized in glassy particles
GB0523638D0 (en) * 2005-11-21 2005-12-28 Cambridge Biostability Ltd Pharmaceutical device for the administration of substances to patients
US20070142287A1 (en) * 2005-12-20 2007-06-21 Biomed Solutions, Llc Compositions And Methods For Treatment Of Cancer
WO2008106571A2 (en) * 2007-02-28 2008-09-04 Abbott Laboratories Sustained release parenteral formulations of buprenorphine
US8444991B2 (en) 2007-03-22 2013-05-21 The Regents Of The University Of Colorado, A Body Corporate Method of preparing an immunologically-active adjuvant-bound dried vaccine composition
EP2470443A2 (en) 2009-08-30 2012-07-04 Aktivpak, Inc. Dispensing device incorporating frangible section, along with dispensing method
US8512679B2 (en) 2011-03-04 2013-08-20 Elwha Llc Glassy compositions
US20130309273A1 (en) 2012-05-17 2013-11-21 Kimberly Hassett Thermostable Vaccine Compositions and Methods of Preparing Same
US20180265402A1 (en) * 2015-09-28 2018-09-20 Dalhousie University Polyphosphate glass microspheres, methods of making and uses thereof
EP3556728A1 (en) * 2018-04-16 2019-10-23 Croda Denmark A/S Organically modified mineral micro-particles, methods of preparing the same and uses thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD247888A1 (de) 1984-01-24 1987-07-22 Univ Schiller Jena Phosphatglaskeramik
GB8903593D0 (en) 1989-02-16 1989-04-05 Pafra Ltd Storage of materials
AU5414990A (en) 1989-04-12 1990-11-05 Aberdeen University Slow release vitreous systems
US5270048A (en) 1989-04-21 1993-12-14 Borden (Uk) Limited Controlled delivery devices
US5562608A (en) 1989-08-28 1996-10-08 Biopulmonics, Inc. Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation
US6290991B1 (en) * 1994-12-02 2001-09-18 Quandrant Holdings Cambridge Limited Solid dose delivery vehicle and methods of making same
US6586006B2 (en) * 1994-08-04 2003-07-01 Elan Drug Delivery Limited Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
US5698318A (en) 1995-05-23 1997-12-16 The Dow Chemical Company Process for resin transfer molding and formulations useful to practice it
GB9705588D0 (en) 1997-03-18 1997-05-07 Anglia Research Foundation Stable particle in liquid formulations
AU2945199A (en) 1998-03-18 1999-10-11 Ronai, Peter Amorphous glasses for stabilising sensitive products
US6190701B1 (en) 1999-03-17 2001-02-20 Peter M. Ronai Composition and method for stable injectable liquids
AU2046101A (en) * 1999-11-22 2001-06-04 Universal Preservation Technologies, Inc. Preservation and formulation of bioactive materials for storage and delivery in hydrophobic carriers
US6623762B2 (en) 2001-02-16 2003-09-23 Cambridge Biostability Ltd. Composition and method for controlled release injections

Also Published As

Publication number Publication date
RU2313366C2 (ru) 2007-12-27
ZA200306375B (en) 2004-08-16
US20020155129A1 (en) 2002-10-24
RU2003127840A (ru) 2005-03-10
US6623762B2 (en) 2003-09-23
NZ527714A (en) 2006-01-27
JP2004522764A (ja) 2004-07-29
KR20030077615A (ko) 2003-10-01
KR100852389B1 (ko) 2008-08-14
CA2438108C (en) 2011-05-31
WO2002066005A1 (en) 2002-08-29
CA2438108A1 (en) 2002-08-29
CN1668275A (zh) 2005-09-14
EP1359899A1 (en) 2003-11-12
MXPA03007312A (es) 2005-02-14
AU2002251931B2 (en) 2007-01-04

Similar Documents

Publication Publication Date Title
IL186782A0 (en) Controlled release composition and method of producing the same
AU2002360670A8 (en) Method and related composition employing nanostructures
AU6832101A (en) Composition and method
IL148803A0 (en) Novel composition and method for stabilizing the same
GB0110288D0 (en) Composition and treatment method
AU4163402A (en) Composition and method
EP1443820A4 (en) COMPOSITION AND METHOD FOR TREATING REACTION OF GRAFT AGAINST HOST
EP1351647A4 (en) COMPOSITIONS AND METHODS FOR TREATING HYPERPIGMENTATION
PL364570A1 (pl) Kompozycja i sposób iniekcji o kontrolowanym uwalnianiu
EP1296660A4 (en) PREPARATION FOR THE CONTROLLED RELEASE OF INSULIN AND ITS MANUFACTURING METHOD
IL157609A0 (en) A vaccine composition and method of using the same
IL161073A0 (en) Composition and method for treating diabetes
GB0126643D0 (en) Composition and process
AU9567201A (en) Vaccine composition and stabilisation method
AU2002245510A1 (en) Method and composition for embalming
AU2002365136A8 (en) Compositions and methods for controlled release
AU2003212866A1 (en) Controlled release compositions and methods for using same
EP1440234A4 (en) METHOD AND MEANS FOR FUEL INJECTION
GB0006867D0 (en) Method and composition for skin lightening
GB0107033D0 (en) Method and composition
GB0130030D0 (en) Composition and method
GB0121627D0 (en) Method and composition
GB0111734D0 (en) Composition and method
AU2002307070A1 (en) Method and composition for controlled release acarbose formulations
HK1107767A1 (en) Pharmaceutical composition and method for treating hypogonadism

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)